Expect steady growth with policy tailwinds
Expecting a solid 1H23
Net profit 1H24 +2.7x YoY, beat expectations
Expecting an upbeat bottom line for 2Q results
China Economy: Exports continued to beat expectations with uncertainty ahead
Expect strong sales in 2023 driven by the US approval of zanubrutinib in CLL
1H23E preview: Expect profit decline on weak coal price
Weak 1Q23 as expected; Expect multiple drivers from iPhone/CPU socket/400G/EV in 2H23E
Optimized CoR guidance beat expectations
1H24 earnings down 27% YoY below our expectation; expect a better 2H24E